Parlux partners with Simpson
This article was originally published in The Rose Sheet
Executive Summary
Singer/actress Jessica Simpson partners with Parlux Fragrances and the Camuto Group to launch her first signature fragrance, the companies announce June 26. Designed to "reflect Simpson's style, personality and confidence," the fragrance line will debut in the U.S. in July 2008, with an international roll-out shortly thereafter, firms say. "Fragrance is a natural product expansion for the Jessica Simpson lifestyle brand," Camuto Group CEO Vince Camuto says. Simpson currently markets clothing, footwear and the Dessert Beauty by Jessica Simpson line of bath and body care. Parlux manufactures and distributes fragrances by Paris Hilton, GUESS?, Andy Roddick, babyGund, and Fred Hayman Beverly Hills, among others...
You may also be interested in...
Jessica Simpson retail Web site
Delivery Agent, Inc. has struck a deal with JT Entertainment to create a Web destination at 1www.SeenOn.com that provides "personal shopper" access to musical artist and entertainer Jessica Simpson, according to an Aug. 20 announcement. The site allows fans to purchase more than 500 products associated with Simpson and her celebrity lifestyle, including clothing, accessories and her upcoming fragrance line from Parlux (2"The Rose Sheet" July 2, 2007, In Brief). "Simpson fans will be able to easily identify and click to purchase products they have seen on the star in photographs as well as through Shopisodes, an online video application that allows consumers to synchronously shop for the items as they watch the video," Delivery Agent explains, noting that its involvement in the "personality branded products arena" will increase with "additional A-list talent deals expected in the coming months." Simpson currently markets the Dessert Beauty by Jessica Simpson bath and body care line; her signature fragrance with Parlux is slated to debut in July 2008...
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.